Dr. Tessa Cook, an associate professor and vice chair of practice transformation in radiology at Penn Medicine, discusses how her team approaches clinical AI implementation. She emphasizes a systematic, "set it and forget it" mindset is unrealistic; instead, AI tools require iterative evaluation, small incremental changes, and continuous stakeholder engagement. Success hinges on respecting clinicians' limited time, running AI pilots sequentially to capture lessons learned, and building strong, ongoing relationships with multidisciplinary stakeholders through regular steering committees.

In this episode, Othman Laraki, CEO of Color, recounts the company’s three major pivots—from a cancer genetics startup to its current health‑tech platform—highlighting the financial, team, and market challenges each transition entailed. He stresses that while technology and product are...

In Episode 9 of Drug Dealin, hosts Kenny and Shibu demonstrate how patients can use publicly available tools like ClinicalTrials.gov and AI language models to uncover novel treatment options, focusing on a hypothetical Parkinson’s disease case inspired by a TV...
The episode discusses the alarming rate of medical errors—estimated at 800,000 to a million deaths annually—and explores how AI can help reduce these mistakes. The host highlights personal experience using AI tools like OpenEvidence, GPT, and Gemini to obtain specialist-level...
In this episode, Dr. Aaron Vinnie shares his journey from a leukemia survivor to a Columbia University hematology‑oncology researcher, advocating a shift from traditional cytotoxic chemotherapy to precision strategies that rewire malignant blood cells. He explains how hematologic cancers stem...

In this episode, Unity Stokes chats with Justin Ayers, CEO of EqualityMD, about the company’s shift from a direct‑to‑consumer, membership model to a B2B/B2B2C platform that offers employers an insurance‑free telehealth solution with culturally competent clinicians and free prescriptions. Ayers...

In this episode, Richard Hanbury of Sana Health discusses the company’s recent FDA De Novo clearance for a novel audio‑visual neuromodulation device targeting neuropathic pain, marking the creation of a new therapeutic class. He outlines decades of research that led...
In this brief clip, host David Williams talks with Dr. Sarah Matt about the critical role of explainability in building trust for AI-driven healthcare. Dr. Matt emphasizes that patients and providers must understand how AI models make decisions to feel...
Dave Newman, MD, Chief Medical Officer of Virtual Care at Sanford Health, explains how the system’s expansive virtual care program—spanning 78 specialties across 300,000 square miles—has become essential for rural patients, saving them an average of 176 miles per visit....

In this live conversation, Dr. Bob Wachter and Dr. Lucy McBride discuss the fragmented state of electronic medical records (EMRs) and how patients and physicians alike are overwhelmed by multiple, non‑communicating digital portals. They highlight federal efforts to create standardized, interoperable...

In this fireside chat, Sami Inkinen, CEO and founder of Virta Health, explains how his personal pre‑diabetes diagnosis inspired the creation of a company that uses nutrition, technology and AI to reverse type‑2 diabetes and obesity. He describes Virta’s massive...
In this episode, Michael Carr, VP and CIO of Health First, discusses the organization’s integrated payer‑provider platform built on Epic’s suite, including the provider rollout and the Epic Tapestry health‑plan implementation. He highlights how consolidating nine disparate systems into a...